Pharmacist Intervention to Improve Smoking Cessation

University of Iowa

Status: Invitation-only

Conditions: Smoking Cessation

Treatments: Behavioral: Pharmacist Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT06943287

202411248

Details and patient eligibility

About

The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit.

The main questions it aims to answer are:

• Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to participate in this study and talk to the pharmacist about smoking cessation?
• Will those in the intervention group be more likely to report smoking cessation than those in the control group.

Participants in the intervention group will be asked to complete a baseline survey; speak with a pharmacist via phone call at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 weeks; and complete an exit survey.

Participants in the control group will be asked to complete a baseline survey and an exit survey.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Current smoker
• Current patient in the Lung Cancer Screening Program

Exclusion criteria

• Unable to speak/read English
• Unable to provide their own written informed consent

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Pharmacist Intervention Group

Experimental group

Treatment:

Behavioral: Pharmacist Intervention

Control Group

No Intervention group